For: | Ma DX, Ding XP, Zhang C, Shi P. Combined targeted therapy and immunotherapy in anaplastic thyroid carcinoma with distant metastasis: A case report. World J Clin Cases 2022; 10(12): 3849-3855 [PMID: 35647147 DOI: 10.12998/wjcc.v10.i12.3849] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v10/i12/3849.htm |
Number | Citing Articles |
1 |
Qiushi Jia, Fulin Li, Chunxiang Li, Changzhi Guo, Shuang Wu, Liguo Hao, Zhongyuan Li. Human epidermal growth factor receptor 2(Her2)-targeted pH-responsive MR/NIRF bimodal imaging-mediated nano-delivery system for the diagnosis and treatment of undifferentiated thyroid cancer. Drug Delivery and Translational Research 2024; doi: 10.1007/s13346-024-01727-2
|
2 |
Xinyu Ying, Xinyi Ma, Ziru Yang, Bo Zhou. Th9 Cytokines Inhibit Proliferation, Promote Apoptosis, and Immune Escape in Thyroid Carcinoma Cells. Applied Biochemistry and Biotechnology 2024; 196(9): 6189 doi: 10.1007/s12010-023-04821-2
|
3 |
|
4 |
Hiroki Komatsuda, Michihisa Kono, Risa Wakisaka, Ryosuke Sato, Takahiro Inoue, Takumi Kumai, Miki Takahara. Harnessing Immunity to Treat Advanced Thyroid Cancer. Vaccines 2023; 12(1): 45 doi: 10.3390/vaccines12010045
|